[Home] [About Us] [News] {directions] [Contact Us] [Directory] [Physician Finder]
[Cancer Care]
[Team]
[Treatment]
[Diagnosis]
[Research]
[Support]
[Immunotherapy]
[Specialty Care]
[Hospital Care]
[Senior Care]
[Immunotherapy]
About Immunotherapy
Clinical Trials
Investigational New Drug Services
Manufacturing Division
News and Announcements
Publications
Quality Control Division
Regulatory Affairs Division

The Cancer Immunotherapy Program currently has the following clinical trials open for enrollment (please click on the links below for detailed summary and eligibility criteria for each trial in PDF format).

Cancer Immunotherapy Clinical Trial Protocols

Type/Stage of Cancer

Clinical Trial Protocol

Description
Recurrent or Treatment Refractory EGFR-positive Non-Small Cell Lung Carcinoma (NSCLC)

RWH# 349-32
EGFRBi-armed ATC
for NSCLC

A Phase I Study of Anti-CD3 x Cetuximab-Armed Activated T Cells, Low Dose IL-2, and GM-CSF for EGFR-Positive, Advanced Non-Small Cell Lung Cancer

 

Home | About Us | News | Research | Contact Us
Directory | Physician Finder
Patient Care Information | Employment Opportunities
Ways of Giving | Content for Physicians